Gut-sparing treatment of urinary tract infection in patients at high risk ofClostridium difficileinfection | Zendy

Christopher Staley | Zendy; Byron P. Vaughn | Zendy; Carolyn Graiziger | Zendy; Michael J. Sadowsky | Zendy; Alexander Khoruts | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Gut-sparing treatment of urinary tract infection in patients at high risk ofClostridium difficileinfection

Author(s) -

Christopher Staley,

Byron P. Vaughn,

Carolyn Graiziger,

Michael J. Sadowsky,

Alexander Khoruts

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkw499

Subject(s) - clostridium difficile , urinary system , medicine , clostridium infections , microbiology and biotechnology , antibiotics , biology

Recipients of faecal microbiota transplantation (FMT) in treatment of recurrent Clostridium difficile infection (RCDI) remain at markedly increased risk of re-infection with C. difficile with new antibiotic provocations. Urinary tract infections (UTIs) are common indications for antibiotics in these patients, often resulting in C. difficile re-infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research